The subcutaneous route is specifically chosen for semaglutide because it allows for gradual absorption into the systemic circulation, providing sustained therapeutic levels throughout the week
Coskun T, Sloop KW, Loghin C, et al
AOM discontinuation was high throughout 2023 and early 2024 due to medication unavailability
The SELECT trial demonstrated a 20% reduction in major cardiovascular events (cardiovascular death, heart attack, stroke) in people with overweight or obesity and established cardiovascular disease
This may increase the risk of preventable complications such as diabetic foot ulcers, vision loss (from diabetic retinopathy), chronic kidney disease, heart attacks, and even strokes 1
Visual signs you can detect Cloudiness or haziness in a reconstituted solution is a clear danger sign